phenofAST

phenofAST has developed a fast and affordable clinical diagnostic solution for antibiotic susceptibility testing, providing definitive test results within 4 hours from a positive culture. Antibiotic susceptibility tests (AST) can take 2 to 3 days to produce definitive results, and with the accelerated spread of antibiotic-resistant bacteria, inappropriate antibiotic treatment results in mortality, morbidity, and higher healthcare costs across all stakeholders. phenofAST is the only company to have completely new & innovative physics-based technology, detecting cell division through laser light interferences, powered by AI analysis. phenofASTs solution provides same day AST test results in a cost effective way for a wide range of indications. This solution is applicable to any microbiology lab due to it's modular design – fit any lab space and needs, Green, minimal waste operation and low price of disposable testing cassette. With phenofAST solution, the microbiology lab will be able to provide the physician with the AST results, enabling the physician to adjust the antibiotic treatment on the same day that the patient was admitted, minimizing AMR ( antimicrobial resistance) and maximizing the right and effective treatment needed. Clinical validations done so far provided very high agreement with the gold standard. phenofAST goal is to become the Standard of Practice in antibiotic susceptibility testing, proving fast, cost-effective and wide-range solution for healthcare providers and payers.

phenofAST was founded in 2018 by Nadav Ben-Dov (Founder & CTO), Aviram Sariel (Co-founder).

phenofAST operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Artificial Intelligence, Image Recognition, Sensing, Laser, Optic, Platforms & Interfaces, Software. Target customers: Healthcare & Life Sciences, Healthcare, Insurance Companies, Providers, Laboratories, Patients, Medical Devices Industry, Medical Equipment, Life Sciences, Biotechnology.

phenofAST is based in Haifa, Israel, North District.